These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 3071348
1. Phase I study of recombinant DNA granulocyte macrophage colony stimulating factor. Steward WP, Scarffe JH, Austin R, Crowther D. Behring Inst Mitt; 1988 Aug; (83):324-6. PubMed ID: 3071348 [Abstract] [Full Text] [Related]
2. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion. Rifkin RM, Hersh EM, Salmon SE. Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327 [Abstract] [Full Text] [Related]
3. Phase I/II study with GM-CSF in patients with myelodysplastic syndromes. Hoelzer D, Ganser A, Greher J, Völkers B, Walther F. Behring Inst Mitt; 1988 Aug; (83):134-8. PubMed ID: 3071328 [Abstract] [Full Text] [Related]
8. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration. Lieschke GJ, Maher D, O'Connor M, Green M, Sheridan W, Rallings M, Bonnem E, Burgess AW, McGrath K, Fox RM. Cancer Res; 1990 Feb 01; 50(3):606-14. PubMed ID: 2404573 [Abstract] [Full Text] [Related]
11. Phase I study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with bone marrow failure and malignancy. Vadhan-Raj S, Kellagher MJ, Keating M, Walters R, Gutterman JU. Behring Inst Mitt; 1988 Aug 01; (83):119-24. PubMed ID: 2467646 [Abstract] [Full Text] [Related]
12. Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation. Klingemann HG, Eaves AC, Barnett MJ, Reece DE, Shepherd JD, Belch AR, Brandwein JM, Langleben A, Koch PA, Phillips GL. Clin Invest Med; 1990 Apr 01; 13(2):77-81. PubMed ID: 2191816 [Abstract] [Full Text] [Related]
13. Phase I clinical study for recombinant human granulocyte colony-stimulating factor. Asano S, Shirafuji N, Watari K, Matsuda S, Uemura N, Ieki R, Kodo H, Takaku F. Behring Inst Mitt; 1988 Aug 01; (83):222-8. PubMed ID: 2467650 [Abstract] [Full Text] [Related]
14. Recombinant granulocyte/macrophage-colony stimulating factor in human and murine bone marrow transplantation. Blazar BR, Widmer MB, Kersey JH, Ramsay NK, McGlave PB, Urdal DL, Gillis S, Henney C, Vallera DA. Behring Inst Mitt; 1988 Aug 01; (83):170-80. PubMed ID: 3071335 [Abstract] [Full Text] [Related]
15. Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study. Steward WP, Scarffe JH, Austin R, Bonnem E, Thatcher N, Morgenstern G, Crowther D. Br J Cancer; 1989 Jan 01; 59(1):142-5. PubMed ID: 2667607 [Abstract] [Full Text] [Related]
16. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials. Nissen-Druey C. Nouv Rev Fr Hematol (1978); 1989 Jan 01; 31(2):99-101. PubMed ID: 2475852 [No Abstract] [Full Text] [Related]
19. [Phase I trial of recombinant human granulocyte-macrophage colony stimulating factor. Results in patients with advanced tumors]. Berthaud P, Eugène-Jolchine I, Spielmann M, Le Chevalier T, Tursz T. Bull Cancer; 1993 May 01; 80(5):418-30. PubMed ID: 8173195 [Abstract] [Full Text] [Related]